These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37837516)

  • 21. Δ
    Banaszkiewicz M; Tarwacka P; Krzywonos-Zawadzka A; Olejnik A; Laprairie R; Noszczyk-Nowak A; Sawicki G; Bil-Lula I
    Front Biosci (Landmark Ed); 2022 Apr; 27(4):114. PubMed ID: 35468673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoids and standardized cannabis extracts inhibit migration, invasion, and induce apoptosis in MCF-7 cells through FAK/MAPK/Akt/NF-κB signaling.
    Suttithumsatid W; Sukketsiri W; Panichayupakaranant P
    Toxicol In Vitro; 2023 Dec; 93():105667. PubMed ID: 37625625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol.
    Ross HR; Napier I; Connor M
    J Biol Chem; 2008 Jun; 283(23):16124-34. PubMed ID: 18390906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor-mediated effects of Δ
    Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
    Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
    Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
    J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells.
    Greenhough A; Patsos HA; Williams AC; Paraskeva C
    Int J Cancer; 2007 Nov; 121(10):2172-80. PubMed ID: 17583570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
    Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
    Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum cannabidiol, tetrahydrocannabinol (THC), and their native acid derivatives after transdermal application of a low-THC Cannabis sativa extract in beagles.
    Hannon MB; Deabold KA; Talsma BN; Lyubimov A; Iqbal A; Zakharov A; Gamble LJ; Wakshlag JJ
    J Vet Pharmacol Ther; 2020 Sep; 43(5):508-511. PubMed ID: 32735381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
    Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
    El-Alfy AT; Ivey K; Robinson K; Ahmed S; Radwan M; Slade D; Khan I; ElSohly M; Ross S
    Pharmacol Biochem Behav; 2010 Jun; 95(4):434-42. PubMed ID: 20332000
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Pellati F; Borgonetti V; Brighenti V; Biagi M; Benvenuti S; Corsi L
    Biomed Res Int; 2018; 2018():1691428. PubMed ID: 30627539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pharmacological characterization of Cannabis sativa chemovar extracts.
    Devsi A; Kiyota B; Ouellette T; Hegle AP; Rivera-Acevedo RE; Wong J; Dong Y; Pugsley MK; Fung T
    J Cannabis Res; 2020 May; 2(1):17. PubMed ID: 33526117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
    Moore CF; Weerts EM
    Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marijuana smoke and Delta(9)-tetrahydrocannabinol promote necrotic cell death but inhibit Fas-mediated apoptosis.
    Sarafian TA; Tashkin DP; Roth MD
    Toxicol Appl Pharmacol; 2001 Aug; 174(3):264-72. PubMed ID: 11485387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
    Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing the antioxidant activity of Δ
    Hacke ACM; Lima D; de Costa F; Deshmukh K; Li N; Chow AM; Marques JA; Pereira RP; Kerman K
    Analyst; 2019 Aug; 144(16):4952-4961. PubMed ID: 31318364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History.
    Berl V; Hurd YL; Lipshutz BH; Roggen M; Mathur EJ; Evans M
    Cannabis Cannabinoid Res; 2022 Dec; 7(6):777-789. PubMed ID: 35787693
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration.
    Karschner EL; Darwin WD; Goodwin RS; Wright S; Huestis MA
    Clin Chem; 2011 Jan; 57(1):66-75. PubMed ID: 21078841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.